AMAG
AMAG Pharmaceuticals
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
182 hedge funds and large institutions have $900M invested in AMAG Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 58 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less call options, than puts
Call options by funds: $6.38M | Put options by funds: $12.1M
Holders
182
Holding in Top 10
2
Calls
$6.38M
Puts
$12.1M
Top Buyers
| 1 | +$4.23M | |
| 2 | +$3.17M | |
| 3 | +$3.04M | |
| 4 |
BlackRock
New York
|
+$2.22M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.92M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$9.12M | |
| 3 | -$7.2M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$3.14M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$2.78M |